Capital Analysts »

iShares Dow Jones US Pharm Indx shares owned by Capital Analysts

Quarter-by-quarter ownership of iShares Dow Jones US Pharm Indx (IHE) shares owned by Capital Analysts from 13F filings

Historical chart of Capital Analysts investment in iShares Dow Jones US Pharm Indx

Tip: Access up to 7 years of quarterly data

All positions including iShares Dow Jones US Pharm Indx held by Capital Analysts consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in iShares Dow Jones US Pharm Indx by Capital Analysts

Quarter filed Position value Share count Share price at filing
2024-03-31 $56k 825 67.88
2023-12-31 $198k 1.1k 185.22
2017-12-31 $20k 130 153.85

More positions owned by Capital Analysts

Spdr Ser Tr Portfolio S&p500 (SPLG)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Msci Eafe (IEFA)
Fidelitymerrimack Str Tr Total Bd Etf (FBND)
Ishares Tr Core S&p Mcp Etf (IJH)
Flexshares Tr Iboxx 5yr Trgt (TDTF)
Microsoft Corporation (MSFT)
Spdr Ser Tr Portfli High Yld (SPHY)
Ishares Tr Core S&p Ttl Stk (ITOT)
Spdrsertr Portfolio S&p600 (SPSM)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Invesco Exchtrdslfidx Rusl 1000 Dynm (OMFL)
Apple (AAPL)
Ssgaactive Etf Tr Mult Ass Rlrtn (RLY)

View all positions for Capital Analysts

Top funds holding iShares Dow Jones US Pharm Indx

Fisher Investments
Morgan Stanley
Bank of America Corporation
Accurate Wealth Management
Royal Bank of Canada
Brown Advisory Holdings Incorporated
Virtue Capital Management
LPL Financial
Wells Fargo & Company
Concord Investment Counsel
Raymond James & Associates
Susquehanna International
Peapack Gladstone Financial Corp
Citadel Advisors
Southern Capital Advisors

View all funds holding iShares Dow Jones US Pharm Indx